BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation
Maxime SartoriiD, Tiago MendesiD, Shruti Desai, Alessia LasorsaiD, Adrien HerlédaniD, Nicolas Malmanche, Petra M. Mäkinen, Mikael MarttineniD, Idir Malki, Julien ChapuisiD, Amandine Flaig, Anaïs-Camille Vreulx, Marion Ciancia, Philippe AmouyeliD, Florence LerouxiD, Benoit P. DepreziD, François‐Xavier CantrelleiD, Damien MaréchaliD, Laurent PradieriD, Mikko HiltuneniD, Isabelle LandrieuiD, Devrim KilinciD, Yann HéraultiD, Jocelyn LaporteiD, Jean‐Charles LambertiD
Abstract
The bridging integrator 1 gene (BIN1) is a major genetic risk factor for Alzheimers disease (AD). In this report, we investigated how BIN1-dependent pathophysiological processes might be associated with Tau. We first generated a cohort of control and transgenic mice either overexpressing human MAPT (TgMAPT) or both human MAPT and BIN1 (TgMAPT;TgBIN1), which we followed-up from 3 to 15 months. In TgMAPT;TgBIN1 mice short-term memory deficits appeared earlier than in TgMAPT mice; however - unlike TgMAPT mice - TgMAPT;TgBIN1 mice did not exhibit any long-term or spatial memory deficits for at least 15 months. After sacrifice of the cohort at 18 months, immunohistochemistry revealed that BIN1 overexpression prevents both Tau mislocalization and somatic inclusion in the hippocampus, where an increase in BIN1-Tau interaction was also observed. We then sought mechanisms controlling the BIN1-Tau interaction. We developed a high-content screening approach to characterize modulators of the BIN1-Tau interaction in an agnostic way (1,126 compounds targeting multiple pathways), and we identified - among others - an inhibitor of Calcineurin, a Ser/Thr phosphatase. We determined that Calcineurin dephosphorylates BIN1 on a Cyclin-dependent kinase phosphorylation site at T348, promoting the open conformation of the neuronal BIN1 isoform. Phosphorylation of this site increases the availability of the BIN1 SH3 domain for Tau interaction, as demonstrated by nuclear magnetic resonance experiments and in primary neurons. Finally, we observed that the levels of the neuronal BIN1 isoform were decreased in AD brains, whereas phospho-BIN1(T348):BIN1 ratio was increased, suggesting a compensatory mechanism. In conclusion, our data support the idea that BIN1 modulates the AD risk through an intricate regulation of its interaction with Tau. Alteration in BIN1 expression or activity may disrupt this regulatory balance with Tau and have direct effects on learning and memory.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 72
- FWCI
- 6.68
- Field percentile
- top 2%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of the Alzheimer’s-linked bridging integrator 1 (BIN1) protein affects synaptic structure and disrupts tau localisation and release
Elizabeth B. C. Glennon, Dawn H. W. Lau, … Wendy J. Noble·Brain CommunicationsPeer-reviewed·Jan 1, 2020
- Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability
Yuliya Voskobiynyk, Jonathan R. Roth, … Erik D. Roberson·eLifePeer-reviewed·Jul 13, 2020
- BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 implicated in Tau pathology
M. Taga, V. A. Petyuk, … P. L. De Jager·bioRxiv·Jan 31, 2019
- Proteomic characterization of the Alzheimer's disease risk factor BIN1 interactome
Joseph D. McMillan, Shuai Wang, … Gopal Thinakaran·Molecular & Cellular ProteomicsPeer-reviewed·Aug 19, 2025
- BIN1 genetic risk factor for Alzheimer is sufficient to induce early structural tract alterations in entorhinal cortex-dentate gyrus pathway and related hippocampal multi-scale impairments
Rachel Daudin, Damien Maréchal, … Michel Simonneau·bioRxiv·Mar 9, 2021
- BIN1 expression in the presynaptic compartment leads to isoform-specific synaptotoxicity
Erwan Lambert, Carla Gelle, … Pierre Dourlen·bioRxiv·Aug 11, 2025